Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: A retrospective chart review
Danika Dai, Courtney Miller, Violeta Valdivia et al. preprint
Abstract BackgroundKetamine has emerged as a rapid-acting antidepressant in treatment-resistant depression (TRD) increasingly used in non-research, clinical settings. Few studies, however, have examined neurocognitive effects of repeated racemic ketamine infusion treatments in patients with TRD. In an effort to identify potential effects after serial infusions, we conducted a retrospective...